Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Wave Life Sci Ord Sh (NQ: WVE )

8.410 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 182
Open 8.410
Bid (Size) 8.280 (1)
Ask (Size) 9.000 (3)
Prev. Close 8.410
Today's Range 8.410 - 8.410
52wk Range 3.510 - 9.920
Shares Outstanding 98,983,261
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics
These two could become direct competitors relatively soon. 
Via The Motley Fool
Wave Life Sciences Announces Closing of Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Wave Life Sciences USA, Inc.
Via GlobeNewswire

Performance

YTD
+57.49%
+57.49%
1 Month
+40.64%
+40.64%
3 Month
+50.99%
+50.99%
6 Month
+39.24%
+39.24%
1 Year
+43.76%
+43.76%

More News

Read More
Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines Conference
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Deep Dive Into WAVE Life Sciences Stock: Analyst Perspectives (4 Ratings)
Via Benzinga
What Analysts Are Saying About WAVE Life Sciences Stock
Via Benzinga
Wave Life Sciences Prices Upsized $200 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
General Motors To $42? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Stitch Fix Reports Weak Earnings, Joins KB Home And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Crude Oil Gains Over 1%; BioVie Shares Plunge
Via Benzinga
Exposures Fossil Fuels
Nasdaq Surges 100 Points; Thor Industries Earnings Top Views
Via Benzinga
Wave Life Sciences Stock Surges On Promising Interim Data From Mid-Stage Study Of Muscular Disorder Drug
Via Benzinga
Wave Life Sciences, Nio, Li Auto, Tesla And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Wave Life Sciences Announces Positive Interim Data from FORWARD-53 Clinical Trial Evaluating WVE-N531 in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
Via MarketBeat
Topics Economy
Exposures Interest Rates
Gene Editing Korro Bio's Preclinical Data 'Best-In-Class', Analyst Initiates With Outperform Rating
Via Benzinga
Wave Life Sciences Receives FDA Rare Pediatric Disease Designation for WVE-N531 for the Treatment of Duchenne Muscular Dystrophy
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
WVE Stock Earnings: WAVE Life Sciences Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Wave Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Wave Life Sciences Second Quarter 2024 Financial Results Scheduled for August 8, 2024
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Worthington Enterprises Posts Downbeat Results, Joins Taysha Gene Therapies, General Mills And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
What's Going On With Wave Life Sciences Stock On Tuesday?
Via Benzinga
Wave Life Sciences Announces Positive Results from Phase 1b/2a SELECT-HD Trial with First Clinical Demonstration of Allele-Selective Mutant Huntingtin Lowering in Huntington’s Disease
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and Leadership in RNA Editing
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Wave Life Sciences to Present at 2024 Jefferies Global Healthcare Conference
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.